Fast Five Quiz: Blastic Plasmacytoid Dendritic Cell Neoplasm Presentation and Diagnosis

Emmanuel C. Besa, MD


February 23, 2021

The triad for diagnosing BPDCN and for differentiating it from other things that may be presenting are positive biomarkers CD123, CD4, and CD56; all three must be positive for histopathologic confirmation of BPDCN.

Just as important are markers that come up negative, eg CD3, CD20, MPO, CD34, and lysozyme. While they may be positive in other cancers such as AML, angiosarcomas and melanomas, they are always negative in BPDCN.

Learn more about the immunophenotypic features of BPDCN.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.